Eledon Pharmaceuticals (ELDN) Cash & Equivalents (2013 - 2026)
Eledon Pharmaceuticals (ELDN) recorded Cash & Equivalents of $6.8 million in Q2 2026, up 18.5% from $5.74 million a year earlier and up 10.6% from the prior quarter.
Eledon Pharmaceuticals (ELDN) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Eledon Pharmaceuticals reported Cash & Equivalents of $22.81 million, up 11.0% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -27.5% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $20.55 million in FY2024 (+345.6%), $4.61 million in FY2023 (-91.8%), $56.41 million in FY2022 (-33.5%) and $84.83 million in FY2021 (-25.7%).
- Quarterly Cash & Equivalents has ranged from $3.67 million in Q3 2023 to $94.04 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in five of the last eight quarters, with growth averaging 44.8%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 345.6% in Q4 2024, against a decline of 94.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.15 million (Q1 2026), $22.81 million (Q4 2025) and $3.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Eledon Pharmaceuticals | 276.12 Mn | 276.12 Mn | - | 6.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.80 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 22.81 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 20.55 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 26.04 Mn |
| Mar 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 40.95 Mn |
| Mar 31, 2023 | 46.50 Mn |
| Dec 31, 2022 | 56.41 Mn |
| Sep 30, 2022 | 65.89 Mn |
| Jun 30, 2022 | 70.46 Mn |
| Mar 31, 2022 | 76.68 Mn |
| Dec 31, 2021 | 84.83 Mn |
| Sep 30, 2021 | 94.04 Mn |
Eledon Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELDN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ELDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();